Drug Trial Radar · NCT00408187
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
Last checked: Nov 19, 2026Latest source record: Jul 30, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
642
Actual
Start
Dec 2006
Primary completion
Dec 2008
Study completion Dec 2008
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 6, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of voclosporin in patients with plaque psoriasis.
Conditions
- Psoriasis
Interventions
voclosporinDrug
voclosporin 0.4 mg/kg po BID
CiclosporinDrug
ciclosporin 1.5 mg/kg po BID
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Superiority in the proportion of subjects achieving a score of "clear" or "almost clear" in the Static Physician's Global Assessment (SPGA) scoreTime frame: Twelve weeks of treatment
Locations
49 sites in 3 countries. Site status is shown where the registry gives one.
Isotechnika Investigational Site
Edmonton, Alberta, Canada
Isotechnika Investigational Site
Surrey, British Columbia, Canada
Isotechnika Investigational Site
Vancouver, British Columbia, Canada
Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
Isotechnika Investigational Site
Halifax, Nova Scotia, Canada
Isotechnika Investigational Site
Barrie, Ontario, Canada
Isotechnika Investigational Site
London, Ontario, Canada
Isotechnika Investigational Site
Markham, Ontario, Canada
Isotechnika Investigational Site
North Bay, Ontario, Canada
Isotechnika Investigational Site
Ottawa, Ontario, Canada
Isotechnika Investigational Site
Waterloo, Ontario, Canada
Isotechnika Investigational Site
Montreal, Quebec, Canada
Isotechnika Investigational Site
Montreal, Quebec, Canada
Isotechnika Investigational Site
Québec, Quebec, Canada
Isotechnika Investigational Site
Ausburg, Germany
Isotechnika Investigational Site
Berlin, Germany
Isotechnika Investigational Site
Berlin, Germany
Isotechnika Investigational Site
Berlin, Germany
Isotechnika Investigational Site
Berlin, Germany
Isotechnika Investigational Site
Bochum, Germany
Isotechnika Investigational Site
Bochum, Germany
Isotechnika Investigational Site
Dresden, Germany
Isotechnika Investigational Site
Dresden, Germany
Isotechnika Investigational Site
Frankfurt, Germany
Isotechnika Investigational Site
Geiβen, Germany
Isotechnika Investigational Site
Hamburg, Germany
Isotechnika Investigational Site
Hamburg, Germany
Isotechnika Investigational Site
Hansestadt Salzwedel, Germany
Isotechnika Investigational Site
Kiel, Germany
Isotechnika Investigational Site
Leipzig, Germany
Isotechnika Investigational Site
Lübeck, Germany
Isotechnika Investigational Site
Mahlow, Germany
Isotechnika Investigational Site
Mainz, Germany
Isotechnika Investigational Site
Münster, Germany
Isotechnika Investigational Site
Potsdam, Germany
Isotechnika Investigational Site
Wuppertal, Germany
Isotechnika Investigational Site
Bialystock, Poland
Isotechnika Investigational Site
Bydgoszcz, Poland
Isotechnika Investigational Site
Gliwice, Poland
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.